Skip NavigationSkip to Content

Qualitative assessment Of IC50 values of inhibitors of the neuronal nicotinic acetylcholine receptor using a single chromatographic experiment and multivariate cluster analysis

  1. Author:
    Jozwiak, K.
    Moaddel, R.
    Yamaguchi, R.
    Ravichandran, S.
    Collins, J. R.
    Wainer, I. W
  2. Author Address

    NIA, Gerontol Res Ctr, NIH, Baltimore, MD 21224 USA. Med Univ Lublin, Dept Chem, PL-20081 Lublin, Poland. Natl Canc Ctr, Frederick SAIC, Adv Biomed Comp Ctr, Ft Detrick, MD 21702 USA Jozwiak, K, NIA, Gerontol Res Ctr, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA
    1. Year: 2005
    2. Date: MAY 5
  1. Journal: Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences
    1. 819
    2. 1
    3. Pages: 169-174
  2. Type of Article: Article
  1. Abstract:

    It has been widely demonstrated that affinity chromatography can be used to derive binding affinities, and that these affinities can be correlated to data obtained using standard techniques such as membrane binding, ultrafiltration and equilibrium dialysis. The purpose of this study is to evaluate the use of immobilized nicotinic acetylcholine receptor stationary phase in chromatographic experiments to assess the functional activity of series of noncompetitive inhibitors (NCIs) as reflected in their IC50 values. Chromatographically determined retention values and computer generated molecular descriptors were obtained for 29 compounds and the data were analyzed by cluster analysis. The approach qualitatively ranked the test compounds as efficient NCIs (low IC50 values) or poor NCIs (high IC50 values). The data obtained with the 29 compounds used in this study demonstrate that the experimental approach had been able to place 25 of these compounds in the correct IC50 clusters. To our knowledge, this is the first relationship established between chromatographic retention and IC50 for membrane-bound receptors. These results suggest that the chromatographic approach may be useful in development of lead drug candidates including the determination of off-target binding. (c) 2005 Elsevier B.V. All rights reserved

    See More

External Sources

  1. DOI: 10.1016/j.jchromb.2005.01.043
  2. WOS: 000228206000022

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel